Artificial Pancreas Device Systems Market Size, Trends, Analysis, and Outlook By Device Type, Threshold Suspended Device System, Control To Range (CTR) System, Control to Target (CTT) System), By End-User (Hospitals and Clinics, Others), by Region, Country, Segment, and Companies, 2024-2030
The global Artificial Pancreas Device Systems market size is poised to register 18.32% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Artificial Pancreas Device Systems market across By Device Type, Threshold Suspended Device System, Control To Range (CTR) System, Control to Target (CTT) System), By End-User (Hospitals and Clinics, Others).
The Artificial Pancreas Device Systems Market is witnessing significant growth and technological innovation driven by the increasing prevalence of type 1 diabetes, insulin-dependent diabetes, and the demand for automated glycemic control solutions to improve glucose management, reduce hypoglycemia risk, and enhance quality of life for individuals with diabetes. Artificial pancreas device systems (APDS) encompass closed-loop insulin delivery systems combining continuous glucose monitoring (CGM) sensors, insulin pumps, and control algorithms to automate insulin dosing and regulate blood glucose levels in real time, mimicking physiological insulin secretion and pancreatic function. Key trends include the development of next-generation APDS technologies, interoperable device platforms, and artificial intelligence (AI) algorithms to optimize glucose prediction, adaptive control strategies, and personalized insulin delivery profiles tailored to individual patient needs and preferences. Additionally, there is a growing emphasis on regulatory pathways, reimbursement policies, and patient access initiatives to facilitate APDS adoption, ensure safety and efficacy, and promote equitable access to advanced diabetes management technologies. Moreover, collaborative clinical research networks, patient registries, and real-world evidence studies are essential for generating robust clinical evidence, advancing APDS innovation, and fostering stakeholder engagement to accelerate the integration of APDS into routine diabetes care practice, improving glycemic outcomes and long-term health outcomes for individuals living with type 1 diabetes worldwide.
Artificial Pancreas Device Systems Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Artificial Pancreas Device Systems market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Artificial Pancreas Device Systems survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Artificial Pancreas Device Systems industry.
Key market trends defining the global Artificial Pancreas Device Systems demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Artificial Pancreas Device Systems Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Artificial Pancreas Device Systems industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Artificial Pancreas Device Systems companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Artificial Pancreas Device Systems industry
Leading Artificial Pancreas Device Systems companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Artificial Pancreas Device Systems companies.
Artificial Pancreas Device Systems Market Study- Strategic Analysis Review
The Artificial Pancreas Device Systems market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Artificial Pancreas Device Systems industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Artificial Pancreas Device Systems Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Artificial Pancreas Device Systems Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Artificial Pancreas Device Systems market segments. Similarly, Strong end-user demand is encouraging Canadian Artificial Pancreas Device Systems companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Artificial Pancreas Device Systems market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Artificial Pancreas Device Systems Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Artificial Pancreas Device Systems industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Artificial Pancreas Device Systems market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Artificial Pancreas Device Systems Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Artificial Pancreas Device Systems in Asia Pacific. In particular, China, India, and South East Asian Artificial Pancreas Device Systems markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Artificial Pancreas Device Systems Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Artificial Pancreas Device Systems Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Artificial Pancreas Device Systems market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Artificial Pancreas Device Systems.
Artificial Pancreas Device Systems Market Company Profiles
The global Artificial Pancreas Device Systems market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Admetsys Corp, Beta Bionics Inc, Bigfoot Biomedical Inc, Defymed, DexCom Inc, Insulet Corp, Johnson & Johnson, Medtronic PLC, Pancreum Inc, Tandem Diabetes Care Inc
Recent Artificial Pancreas Device Systems Market Developments
The global Artificial Pancreas Device Systems market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Artificial Pancreas Device Systems Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others
Geographical Segmentation:
Admetsys Corp
Beta Bionics Inc
Bigfoot Biomedical Inc
Defymed
DexCom Inc
Insulet Corp
Johnson & Johnson
Medtronic PLC
Pancreum Inc
Tandem Diabetes Care Inc
Formats Available: Excel, PDF, and PPT
The Artificial Pancreas Device Systems Market is witnessing significant growth and technological innovation driven by the increasing prevalence of type 1 diabetes, insulin-dependent diabetes, and the demand for automated glycemic control solutions to improve glucose management, reduce hypoglycemia risk, and enhance quality of life for individuals with diabetes. Artificial pancreas device systems (APDS) encompass closed-loop insulin delivery systems combining continuous glucose monitoring (CGM) sensors, insulin pumps, and control algorithms to automate insulin dosing and regulate blood glucose levels in real time, mimicking physiological insulin secretion and pancreatic function. Key trends include the development of next-generation APDS technologies, interoperable device platforms, and artificial intelligence (AI) algorithms to optimize glucose prediction, adaptive control strategies, and personalized insulin delivery profiles tailored to individual patient needs and preferences. Additionally, there is a growing emphasis on regulatory pathways, reimbursement policies, and patient access initiatives to facilitate APDS adoption, ensure safety and efficacy, and promote equitable access to advanced diabetes management technologies. Moreover, collaborative clinical research networks, patient registries, and real-world evidence studies are essential for generating robust clinical evidence, advancing APDS innovation, and fostering stakeholder engagement to accelerate the integration of APDS into routine diabetes care practice, improving glycemic outcomes and long-term health outcomes for individuals living with type 1 diabetes worldwide.
Artificial Pancreas Device Systems Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Artificial Pancreas Device Systems market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Artificial Pancreas Device Systems survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Artificial Pancreas Device Systems industry.
Key market trends defining the global Artificial Pancreas Device Systems demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Artificial Pancreas Device Systems Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Artificial Pancreas Device Systems industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Artificial Pancreas Device Systems companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Artificial Pancreas Device Systems industry
Leading Artificial Pancreas Device Systems companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Artificial Pancreas Device Systems companies.
Artificial Pancreas Device Systems Market Study- Strategic Analysis Review
The Artificial Pancreas Device Systems market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Artificial Pancreas Device Systems industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Artificial Pancreas Device Systems Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Artificial Pancreas Device Systems Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Artificial Pancreas Device Systems market segments. Similarly, Strong end-user demand is encouraging Canadian Artificial Pancreas Device Systems companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Artificial Pancreas Device Systems market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Artificial Pancreas Device Systems Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Artificial Pancreas Device Systems industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Artificial Pancreas Device Systems market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Artificial Pancreas Device Systems Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Artificial Pancreas Device Systems in Asia Pacific. In particular, China, India, and South East Asian Artificial Pancreas Device Systems markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Artificial Pancreas Device Systems Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Artificial Pancreas Device Systems Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Artificial Pancreas Device Systems market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Artificial Pancreas Device Systems.
Artificial Pancreas Device Systems Market Company Profiles
The global Artificial Pancreas Device Systems market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Admetsys Corp, Beta Bionics Inc, Bigfoot Biomedical Inc, Defymed, DexCom Inc, Insulet Corp, Johnson & Johnson, Medtronic PLC, Pancreum Inc, Tandem Diabetes Care Inc
Recent Artificial Pancreas Device Systems Market Developments
The global Artificial Pancreas Device Systems market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Artificial Pancreas Device Systems Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Admetsys Corp
Beta Bionics Inc
Bigfoot Biomedical Inc
Defymed
DexCom Inc
Insulet Corp
Johnson & Johnson
Medtronic PLC
Pancreum Inc
Tandem Diabetes Care Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Artificial Pancreas Device Systems Market Overview and Key Findings, 2024
1.2 Artificial Pancreas Device Systems Market Size and Growth Outlook, 2021- 2030
1.3 Artificial Pancreas Device Systems Market Growth Opportunities to 2030
1.4 Key Artificial Pancreas Device Systems Market Trends and Challenges
1.4.1 Artificial Pancreas Device Systems Market Drivers and Trends
1.4.2 Artificial Pancreas Device Systems Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Artificial Pancreas Device Systems Companies
2. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET SIZE OUTLOOK TO 2030
2.1 Artificial Pancreas Device Systems Market Size Outlook, USD Million, 2021- 2030
2.2 Artificial Pancreas Device Systems Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Artificial Pancreas Device Systems Market, 2025
5.2 Asia Pacific Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Artificial Pancreas Device Systems Market, 2025
5.5 Europe Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.6 Europe Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Artificial Pancreas Device Systems Market, 2025
5.8 North America Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.9 North America Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Artificial Pancreas Device Systems Market, 2025
5.11 South America Pacific Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.12 South America Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Artificial Pancreas Device Systems Market, 2025
5.14 Middle East Africa Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Artificial Pancreas Device Systems Market Size Outlook and Revenue Growth Forecasts
6.2 US Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Artificial Pancreas Device Systems Industry Drivers and Opportunities
7. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ARTIFICIAL PANCREAS DEVICE SYSTEMS COMPANY PROFILES
8.1 Profiles of Leading Artificial Pancreas Device Systems Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Admetsys Corp
Beta Bionics Inc
Bigfoot Biomedical Inc
Defymed
DexCom Inc
Insulet Corp
Johnson & Johnson
Medtronic PLC
Pancreum Inc
Tandem Diabetes Care Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Artificial Pancreas Device Systems Market Overview and Key Findings, 2024
1.2 Artificial Pancreas Device Systems Market Size and Growth Outlook, 2021- 2030
1.3 Artificial Pancreas Device Systems Market Growth Opportunities to 2030
1.4 Key Artificial Pancreas Device Systems Market Trends and Challenges
1.4.1 Artificial Pancreas Device Systems Market Drivers and Trends
1.4.2 Artificial Pancreas Device Systems Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Artificial Pancreas Device Systems Companies
2. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET SIZE OUTLOOK TO 2030
2.1 Artificial Pancreas Device Systems Market Size Outlook, USD Million, 2021- 2030
2.2 Artificial Pancreas Device Systems Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Device Type
Threshold Suspended Device System
Control To Range (CTR) System
Control to Target (CTT) System
By End-User
Hospitals and Clinics
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Artificial Pancreas Device Systems Market, 2025
5.2 Asia Pacific Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Artificial Pancreas Device Systems Market, 2025
5.5 Europe Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.6 Europe Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Artificial Pancreas Device Systems Market, 2025
5.8 North America Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.9 North America Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Artificial Pancreas Device Systems Market, 2025
5.11 South America Pacific Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.12 South America Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Artificial Pancreas Device Systems Market, 2025
5.14 Middle East Africa Artificial Pancreas Device Systems Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Artificial Pancreas Device Systems Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Artificial Pancreas Device Systems Market Size Outlook and Revenue Growth Forecasts
6.2 US Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Artificial Pancreas Device Systems Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Artificial Pancreas Device Systems Industry Drivers and Opportunities
7. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ARTIFICIAL PANCREAS DEVICE SYSTEMS COMPANY PROFILES
8.1 Profiles of Leading Artificial Pancreas Device Systems Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Admetsys Corp
Beta Bionics Inc
Bigfoot Biomedical Inc
Defymed
DexCom Inc
Insulet Corp
Johnson & Johnson
Medtronic PLC
Pancreum Inc
Tandem Diabetes Care Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
